GL Pharm Tech Corrects Unregistered Executive Pay Total to KRW 538.66 Million

PUBT · 1d ago
GL Pharm Tech Corrects Unregistered Executive Pay Total to KRW 538.66 Million
  • GL Pharm Tech corrected its September 2026 quarterly report on November 13 to address omissions in executive disclosures.
  • Total pay for unregistered executives was revised to KRW 538.66 million from KRW 223.72 million.
  • The executive headcount rose to seven from five; average pay increased to KRW 76.95 million from KRW 44.74 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GL Pharm Tech Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000746), on November 13, 2026, and is solely responsible for the information contained therein.